Investor directory

Ben Franklin Technology Partners of Southeastern Pennsylvania

Ben Franklin Technology Partners of Southeastern Pennsylvania, established in 1982, is a non-profit organization that fosters technological innovation and growth in the region. It primarily invests in early-stage technology companies, having supported over 1,750 such ventures since its inception. The organization also facilitates university-industry partnerships to accelerate scientific discoveries to market, and initiates regional programs to bolster the entrepreneurial ecosystem. Its mission is to create jobs and transform lives by leading the region's technology community to new heights.
http://www.sep.benfranklin.org
https://crunchbase.com/organization/ben-franklin-technology-partners-of-southeastern-pennsylvania
https://facebook.com/bftp.sep
https://linkedin.com/company/ben-franklin-technology-partners-of-southeastern-pennsylvania
https://pitchbook.com/profiles/advisor/11138-68
https://signal.nfx.com/firms/ben-franklin-technology-partners-of-southeastern-pennsylvania
https://twitter.com/bftp_sep
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=19149
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=54495774
https://www.privateequityinternational.com/database/#/profile?id=15552

Jonathan Beschen

Investment Director, Information Technology Investment Group

Anthony George

Venture Capital Associate, Tech Investment Group

Omar Mencin

Managing Director, Information Technology Investment Group

Scott Nissenbaum

President, CEO and Board Member

Aston Pierce

Director - GO PA Fund and GO PHL Fund

Kathie Jordan Ph.D

Managing Director, Healthcare Investment Group

Past deals in Nanotechnology

Avisi Technologies

Seed Round in 2022
Avisi Technologies Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing innovative solutions for glaucoma treatment. Founded in 2017, the company has created VisiPlate, a next-generation aqueous shunt that utilizes nanotechnology to provide a defense against blindness caused by glaucoma. This advanced technology aims to improve the effectiveness of glaucoma treatments and enhance patient outcomes.

Avisi Technologies

Seed Round in 2021
Avisi Technologies Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing innovative solutions for glaucoma treatment. Founded in 2017, the company has created VisiPlate, a next-generation aqueous shunt that utilizes nanotechnology to provide a defense against blindness caused by glaucoma. This advanced technology aims to improve the effectiveness of glaucoma treatments and enhance patient outcomes.

Avisi Technologies

Seed Round in 2019
Avisi Technologies Inc. is a company based in Philadelphia, Pennsylvania, that focuses on developing innovative solutions for glaucoma treatment. Founded in 2017, the company has created VisiPlate, a next-generation aqueous shunt that utilizes nanotechnology to provide a defense against blindness caused by glaucoma. This advanced technology aims to improve the effectiveness of glaucoma treatments and enhance patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.